Guangdong Hexin Health Technology Co., Ltd.

Guangdong Hexin Health Technology Co., Ltd. (Hexin Health) was established in 2015 and is located at the industry-university-research base of the State Key Laboratory of Respiratory Diseases, a member of the industry-university-research sub-center of the National Clinical Research Center for Respiratory Diseases, an important council member of the Infectious Disease Diagnostic Reagent Industry Technology Innovation Alliance of the Guangdong Provincial Department of Science and Technology, and a Guangdong Provincial enterprise-level "Respiratory Virus Diagnostic Reagent Engineering Technology Research Center", equipped with an enterprise-level P2 virus laboratory. Hexin Health is a national high-tech enterprise integrating research and development, production, and sales of raw materials and products for rapid in vitro diagnostic testing of respiratory pathogens, and is one of the leading enterprises in respiratory pathogen detection in China. Hexin Health has established extensive sales channels both domestically and internationally, possesses first-class scientific research personnel at home and abroad, and cooperates with multiple authoritative medical institutions worldwide. As of the end of 2022, the company has obtained 25 Class I medical device registration certificates, 17 Class II registration certificates, 13 Class III registration certificates, and 76 overseas registration certificates. It is planning to establish branches in Singapore, Europe, the United States, and Africa to promote a global manufacturing system; meanwhile, it is laying out a global marketing service network, having established stable cooperative relationships with customers in more than 70 countries and regions, providing product solutions and technical support. It is widely applied in clinical testing, critical care, primary medical care, epidemic monitoring, disaster rescue, and personal health management. Hexin Health is located in Guangzhou Science City and has built comprehensive technology platforms including rapid molecular diagnostics, colloidal gold labeling chromatography, fluorescence-labeled quantitative detection, flow cytometry, and electrochemical quantitative detection. The company has established a 5,000 square meter industrialization base for rapid diagnostic products, equipped with a 5,000 square meter clean production workshop and internationally advanced rapid diagnostic reagent production lines, with an annual output of over 100 million person-times. Hexin Health's mission is to safeguard human respiratory health, adhering to the principles of independent research and innovation, deeply cultivating the development of diagnostic reagents for respiratory infectious diseases; committed to providing users with more accurate, more sensitive, more convenient, and faster diagnostic products, and striving to become a diagnostic expert in respiratory pathogen diagnostic solutions! Our mission: Safeguard human respiratory health! Our vision: A comprehensive supplier of respiratory disease diagnostic solutions! Core values: More accurate, more sensitive, more convenient, faster